Biotech · Private company · Houston, TX, US
Well Cell Global
Track this companyFree. Adds Well Cell Global to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Physiologic Insulin Resensitization (PIR)Chronic Kidney Disease (Stages 4 and 5)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Physiologic Insulin Resensitization (PIR) Treatment in Patients With a Diagnosis of Type 2 Diabetes Mellitus (T2DM)NA · NOT_YET_RECRUITING · started Oct 26, 2026ClinicalTrials.gov NCT07906470 · fetched Nov 12, 2026
- Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes MellitusNA · RECRUITING · started Oct 14, 2025ClinicalTrials.gov NCT07187479 · fetched Nov 12, 2026
NIH awards1
- Metabolic Responses to Physiologic Insulin Resensitization in Type 2 DiabetesFiscal year 2026 · $1MNIH RePORTER 1R44DK148354-01 · fetched Nov 12, 2026